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tumors, where they have been shown to be important in tumor
maintenance/progression (Schatton et al., 2008; Jordan, 2009).
Such cells were less evident in precancerous nevi or early
tumors, raising questions regarding the origin of these cells
and suggesting that they may be critical for progression of
advanced cancer as opposed to cancer initiation.
There is therapeutic interest in cancer stem cells because they
have properties distinct from the remainder of the tumor. They
express multidrug-resistant transporters, such as Abcg2, that
can efflux chemotherapy drugs, and the cells are frequently
slow growing or quiescent, affording them relative resistance
to therapies that target rapidly growing cancer cells (Zhang
and Rosen, 2006; Lobo et al., 2007; Dalerba et al., 2007; Robey
et al., 2007; Dirks, 2008). It is suggested that quiescent cancer
stem cells that survive cancer treatment may remain dormant
for long periods, only to reinitiate proliferation at some point in
the future and restore the original tumor (Zhang and Rosen,
2006). Much of the research effort on cancer stem cells has
focused on cell surface markers such as CD133 on brain tumors
and a CD44-high/CD24-low pattern on breast cancers (Dalerba
et al., 2007; Dick, 2005; Lobo et al., 2007; O’Brien et al., 2007;
Zhang and Rosen, 2006; Mani et al., 2008; Dirks, 2008). Although
such markers have been used to identify and isolate cells with
properties of cancer stem cells, substantial differences have
been reported in markers not only in cells from different tumors
but also among patients with similar tumors (reviewed in Jordan,
2009). Such diversity of markers in cells from patients with similar
tumors raises questions as to whether cancer stem cells are
derived from a common stem cell progenitor.
A recent study from the Weinberg laboratory has provided
evidence that cells with at least some of the properties of stem
cells and cancer stem cells can be induced from differentiated
somatic cells by overexpression of E box binding transcription
factors including Snai, Twist, and Zeb family members (Mani
et al., 2008). These transcription factors all have been shown
to be overexpressed in carcinomas, where they drive epithe-
lial-to-mesenchymal transition (EMT), which is thought to facili-
tate a metastatic phenotype in late-stage cancers. However,
these new studies demonstrated that overexpression of the
EMT transcription factors has a hitherto unanticipated role inSUMMARY
Activation of the RB1 pathway triggers the cell-cycle
arrest that mediates cell-cell contact inhibition.
Accordingly,mutationof all threeRB1 familymembers
leads to loss of contact inhibition and outgrowth
of fibroblasts into spheres where cell-cell contacts
predominate. We present evidence that such out-
growth triggers reprogramming to generate cells
with properties of cancer stem cells. Fibroblasts with
only a single RB1 mutation remain contact inhibited;
however, if this contact inhibition is bypassed by
forcing the RB1/ cells to form spheres in suspen-
sion, cells with properties of cancer stem cells are
also generated. These cells not only form tumors in
nude mice but also generate differentiated cells. We
propose that contact inhibition imposed by the RB1
pathway performs an unexpected tumor suppressor
function by preventing cell outgrowth into structures
where cells with properties of cancer stem cells can
be generated from differentiated somatic cells in
advancing cancers.
INTRODUCTION
Solid tumors as well as cancers of hematopoietic origin have
been shown to contain a small population of cancer-initiating
cells, designated cancer stem cells, that in xenographic trans-
plants are capable of regenerating the heterogeneous popula-
tion of cancer cells in a tumor (Dalerba et al., 2007; Dick, 2005;
Lobo et al., 2007; O’Brien et al., 2007; Trosko, 2006; Zhang
and Rosen, 2006). As their name implies, cancer stem cells
have some properties of embryonic stem cells (ESCs), including
expression of ESC genes and the ability to divide asymmetrically
to generate cancer cells while maintaining their number in the
tumor. Because such properties are thought to be reserved for
stem cells, it has been postulated that cancer stem cells and
thus cancers arise from transformation of resident stem cells in
tissues. However, in at least some cancers, such as melanoma,
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cells, which coincides with their acquisition of properties of
stem cells and cancer stem cells. Chang’s laboratory has also
recently demonstrated that an ESC gene expression module
and properties of cancer stem cells can be induced in primary
culture keratinocytes, and c-Myc is central to this process
(Wong et al., 2008). c-Myc amplification is linked to initiation of
EMT in breast cancer (Trimboli et al., 2008). Also, c-Myc is
a classic target of Wnt, whose signaling triggers EMT at least
in part through activation of EMT transcription factors (Neth
et al., 2007; Stemmer et al., 2008). Taken together, these studies
provide evidence that cells with properties of cancer stem cells
can be generated from differentiated somatic cells.
Recent studies have begun to provide evidence that at
least some cancers originate in differentiated somatic cells as
opposed to stem cells or progenitor cells. One such cancer, reti-
noblastoma, is a pediatric tumor of the retina and perhaps the
best-defined tumor with regard to mutations leading to cancer
(MacPherson and Dyer, 2007). Initiation of retinoblastoma in
humans appears to require only mutation of both copies of the
retinoblastoma tumor suppressor RB1. Using a mouse model
of retinoblastoma, it has been demonstrated that differentiated
horizontal interneurons in the inner nuclear layer of the retina
are the target of transformation, as opposed to a stem cell or
progenitor cell as previously presumed (Ajioka et al., 2007;
te Riele, 2007). While initiation of retinoblastoma appears to
involve outgrowth of these differentiated neurons, it is of note
that highly aggressive cancer cells (lacking neuronal markers),
as well as cells with properties of cancer stem cells, subse-
quently appear in retinoblastomas (Seigel et al., 2005, 2007;
MacPherson and Dyer, 2007). These results in this mouse model
of retinoblastoma, taken together with the findings discussed
above, raise the possibility that cancer stem cells can be derived
from differentiated somatic cells, and that such cells may be
somehow generated in advancing tumors.
Beyond retinoblastoma, mutation or inactivation of the RB1
pathway via hyperphosphorylation catalyzed by cyclin-depen-
dent kinases (cdks) occurs in virtually all cancers, suggesting
that inhibition of this pathway plays a general role in cancer initi-
ation. A hallmark of all solid tumors is the outgrowth of cancer
cells into three-dimensional (3D) structures. The RB1 pathway
is crucial for imposing the cell-cycle arrest that mediates cell-
cell contact inhibition (Zhang et al., 1999; Sage et al., 2000;
Dannenberg et al., 2000), and accordingly fibroblasts in which
all three RB1 family members, RB1, RBL1, and RBL2, have
been mutated (triple knockouts [TKOs]) lack contact inhibition
and grow into 3D colonies or mounds in cell culture (Dannenberg
et al., 2000; Sage et al., 2000). We hypothesized that the
outgrowth of cells into such spherical structures where cell-cell
contacts predominate may play an active role in reprogramming
somatic cells to a cancer-stem-cell-like phenotype.
Here, we provide evidence that outgrowth of TKO MEFs into
spheres indeed leads to stable reprogramming of the cells to
a cancer stem cell phenotype. While fibroblasts containing only
an RB1 mutation retain cell contact inhibition, bypassing this
inhibition by forcing the cells to form spheres in suspension leads
to similar reprogramming of the RB1/ cells to a cancer stem
cell phenotype. These cells not only divide asymmetrically to
produce cancer cells but also generate differentiated cells. Ourresults provide evidence of a potential pathway for generation
of cancer stem cells from differentiated somatic cells as a
consequence of tumor outgrowth. Based on these findings, we
suggest a novel tumor suppressor function for the RB1 pathway
in imposing contact inhibition to prevent outgrowth of differenti-
ated somatic cells into structures where reprogramming to
cancer stem cells can occur.
RESULTS
RB1 Family Mutation Allows Outgrowth of Cells into
Spheres, Leading to Survival in Suspension and Stable
Changes in Cell Morphology
Consistent with their lack of cell-cell contact inhibition, once
mouse embryo fibroblasts (MEFs) in which all three RB1 family
members had been mutated (TKOs) became confluent in culture,
they began to form 3D colonies or mounds of cells on the plate
(Dannenberg et al., 2000; Sage et al., 2000; Figures 1A and 1B).
Similar results were seen with cells at passages 4, 11, and 40
and cells from four different litters (results not shown). Subse-
quently, outgrowth of cells in these mounds led to detachment
of the mounds from the culture plate and formation of spheres
in suspension (Figures 1C and 1D). This sphere formation was
efficient, and with time, most TKO cells on the plate formed
spheres. By contrast to TKOs, wild-type MEFs,RB1/ MEFs, or
MEFs with two RB1 family members mutated, RB1//RBL2/
MEFs, remained contact inhibited, and thus did not form such
mounds or spheres (results not shown). The TKO spheres visually
resembled embryoid bodies seen when embryonic stem cells are
placed in suspension culture (Figures 1C and 1D; Desbaillets
et al., 2000), and when transferred to plates that do not permit
adherence, these spheres could be maintained for months in
suspension. During this period, they increased in size and formed
a central cavity (Figure 1E). When the spheres were transferred
back to a tissue culture plate that allows adherence of cells,
they adhered to the plate, and all of the cells within the spheres
migrated back onto the plate, reforming a monolayer (Figures
1F and 1G). Surprisingly, none of the cells in these monolayers
resembled TKOs prior to sphere formation—they were smaller
and morphologically heterogeneous (compare Figure 1A to
Figures 1H and 1I). These sphere-derived TKOs retained this
smaller size and distinct morphology as they were passaged in
culture, demonstrating a stable morphological transition. We
never observed generation of cells with such morphology in
TKOs maintained in subconfluent monolayer cultures, even after
40 passages (results not shown).
If a monolayer of TKOs was trypsinized and the resulting cells
were placed in suspension culture, spheres did not form, and the
single cells began to die after 24 hr in suspension (results not
shown). However, if TKOs from confluent monolayers were
scraped from plates (without trypsinization), the cells formed
spheres in suspension. Such spheres were indistinguishable in
all experiments described below from mound-derived cells that
spontaneously detached from confluent TKO cultures. Consis-
tent with their lack of survival in suspension culture, trypsinized
TKO did not form colonies in soft agar, nor did they form tumors
in nude mice (results not shown).
The above studies suggest that cell-cell contact affords
TKO MEFs resistance to death in suspension, and the stableCell Stem Cell 4, 336–347, April 3, 2009 ª2009 Elsevier Inc. 337
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Figure 1. Sphere Formation Triggers Stable
Changes in TKO Morphology
(A) TKOs at passage 4 in monolayer culture.
(B) TKOs lack contact inhibition and form mounds
after reaching confluence in culture.
(C) Outgrowth of mounds, such as those shown in
(B), subsequently leads to detachment from the
plate and sphere formation.
(D) TKO spheres are shown 2 weeks after transfer
to a nonadherent plate.
(E) Central cavity formation (arrow) becomes
evident in TKO spheres after several weeks in
suspension culture.
(F) TKO spheres formed in suspension culture
reattached when transferred back to tissue culture
plates, and all cells in the spheres migrate back
onto the plate to reform a monolayer.
(G) Higher-power view of the boxed region in (F).
(H) Monolayers of sphere-derived cells 2 days after
spheres were transferred back to a tissue culture
plate.
(I) Cells in (H) after 1 week in culture. Note that cells
in (H) and (I) have diverse morphologies, and they
are smaller than TKO cells prior to sphere forma-
tion (A).338 Cell Stem Cell 4, 336–347, April 3, 2009 ª2009 Elsevier Inc.the above results suggest that bypassing cell-cell contact inhibi-
tion in monolayer culture and forcing RB1/ MEFs to form
spheres also leads to stable changes in cell morphology. It is of
note that we observed similar sphere formation with wild-type
MEFs, and RB1 family mRNA expression was not downregulated
duringsphere formation (FigureS2), suggesting thatsphere forma-
tion per se does not require downregulation of the RB1 family.
Sphere Formation in TKOs and RB1/ MEFs
Leads to Expression of ESC Genes
Because cells in the spheres undergo a stable change in
morphology that may reflect reprogramming, we used real-
time PCR to examine expression of ESC gene mRNAs in cells
derived from spheres after 2 weeks in suspension culture, and
these results were compared to cells maintained as subconflu-
ent monolayers. These mRNAs included Oct-4, Nanog, Sox2,
and Klf4, whose expression is associated with reprogramming of
fibroblasts to a stem cell phenotype (Figure 2A). Expression of
both Oct-4 and Nanog mRNA increased during a time course
of RB1/ MEF sphere formation in suspension culture
(Figure 2B). To confirm Oct-4 protein expression, spheres were
immunostained for Oct-4. After 4 days in suspension, we only
observed low-level cytoplasmic staining for Oct-4 (Figure 2C).
Even though this cytoplasmic staining was dependent upon
the primary antibody, little or no Oct-4 mRNA was detected at
this time (Figure 2B). Thus, this cytoplasmic immunostaining
does not appear to be specific for Oct-4, and as suggested
previously, it may arise from expression of Oct-4 pseudogenes
(Lengner et al., 2007). After 8 days in suspension culture, nuclear
immunostaining for Oct-4 became evident in clusters of cells in
the spheres; this nuclear immunostaining further increased at
24 days, and during this period there was also an increase in
the level of Oct-4 mRNA by real-time PCR (Figures 2B and 2C).
Nanog is a downstream target of Oct-4, and thus its expression
is a functional readout of Oct-4 activity. The level of Nanogmorphological changes imply that the cells are undergoing
reprogramming (e.g., differentiation or dedifferentiation) in the
context of the spheres.
Sphere Formation inRB1/MEFsAlso Leads to Survival
in Suspension and Stable Morphological Changes
As noted above, persistence of contact inhibition inRB1/MEFs
mediated by the other two RB1 family members, RBL1 and RBL2,
prevented formation of mounds and in turn spheres in monolayer
culture. However, scraping confluent monolayers of TKO cells
and placing the cells in suspension culture led to formation of
spheres with properties indistinguishable from those seen in
spheres derived from mounds that spontaneously detached
from confluent plates. Therefore, we postulated that bypassing
contact inhibition by scraping confluent RB1/ MEFs from
plates and placing them in suspension culture may lead to sphere
formation and generation of cells with distinct morphology.
Indeed, when scraped from plates, RB1/ MEFs formed
spheres in suspension as efficiently as TKOs, and the spheres
were indistinguishable morphologically from those formed with
TKOs, and they increased in size and remained viable for months
in culture (results not shown). As with TKO spheres,RB1/ MEF
spheres reattached when transferred to a tissue culture plate
allowing adhesion, and all cells in the spheres migrated back
onto the plate to reform a monolayer; also, as with TKO-sphere-
derived cells, RB1/ cells in these monolayers were small,
morphologically diverse, and distinct from the original RB1/
MEFs (results not shown). Real-time PCR demonstrated that
mRNAs for the other two RB1 family members, RBL1 and RBL2,
were initially downregulated in the RB1/ spheres at day 4 in
suspension culture, potentially accounting for the loss of contact
inhibition in the spheres (Figure 2A). However, RBL2 mRNA
expression resumed after day 8 in suspension (Figure 2A), and
it was maintained in sphere-derived cells migrating back onto
a culture dish (see Figure S1 available online). Taken together,
Cell Stem Cell




Figure 2. Sphere Formation Leads to Expression of ESC mRNAs in TKO and RB1/ MEF Spheres, and to Downregulation of RB1 Family
Members in RB1/ MEFs
(A) Real-time PCR showing expression of mRNAs for ESC markers and RB1 family members in RB1/ MEF spheres in suspension culture. ESC genes were
analyzed after 2 weeks in suspension culture, and RB1 family members were analyzed at the indicated times.
(B) Oct-4 and Nanog mRNA increase in RB1/ spheres with the number of days (d) in culture. Real-time PCR was used to analyze mRNA levels.
(C) Immunostaining for Oct-4 is shown in sections of RB1/ MEFs after 4 and 24 days in culture. The right panel is a higher-power view. Note only cytoplasmic
staining at 4 days, whereas nuclear staining is evident at 24 days. No staining was evident in the absence of the Oct-4 primary antibody.
(D) Real-time PCR results demonstrating changes in expression of other mRNA associated with stem cells and cancer stem cells after 2 weeks in suspension
culture (also see Figures S1 and S3). The comparison is to cells in subconfluent monolayers.
Error bars indicate standard deviations.A Subset of Cells with Properties of a Side Population
Is Generated in TKO and RB1/ MEF Spheres
Multipotential stem cells in bone marrow and other tissues have
been characterized as a side population (SP) based on their prop-
erties compared to the major population (MP) of cells present
(reviewed in Challen and Little, 2006). Also, these SP characteris-
tics are shared by a small subset of cells in tumors, referred to as
cancer stem cells, that can recapitulate the tumor heterogeneity
in transplantation assays (Hirschmann-Jax et al., 2005). In addi-
tion to tumor cells, cancer stem cells can also give rise to
differentiated cells (Dirks, 2008). Because of the re-expression
of ESC genes and the stable changes in morphology seen in
sphere-derived cells, we wondered if sphere formation might
be reprogramming the RB1 pathway mutant fibroblasts to
generate SP cells with properties of stem cells or cancer stem
cells. Among the characteristics of SP cells is expression of multi-
drug-resistant transporters such as Abcg2 and the accompa-
nying ability to exclude Hoechst 33342 dye (and chemotherapy
drugs) (Robey et al., 2007).mRNA paralleled that of Oct4 during this time course of sphere
culture (Figure 2B). In addition to these ESC-specific genes,
we also noted upregulation of other genes associated with
stem cells in both TKO and RB1/ MEF spheres (Figures 2D
and S1). A similar pattern of expression of ESC-associated
genes was maintained as sphere-derived RB1/ cells migrated
out of spheres to reform a monolayer on tissue culture dishes
(Figure S3). These results suggested that at least some cells
in the spheres are re-expressing ESC-associated genes.
Because re-expression of such genes in fibroblasts is sufficient
to reprogram the cells to pluripotency, it was possible that the
re-expression of these genes that we observed in the spheres
was inducing reprogramming of the fibroblasts, which was
reflected in the stable changes in morphology. It is also of note
that mRNAs for CD44 and CD133 were induced, and CD24
mRNA was downregulated (Figure 2D). This is a pattern of
expression seen in some cancer stem cells, raising the question
as to whether some of the cells in the spheres may have cancer
stem cell properties.Cell Stem Cell 4, 336–347, April 3, 2009 ª2009 Elsevier Inc. 339
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Figure 3. Sphere Formation in TKOs or RB1/ MEFs Generates Cells with Characteristics of a Tumor SP
Immunostaining for Abcg2 and CD133 is shown on the left, and Hoechst dye staining is shown on the right.
(A) TKOs in subconfluent monolayer culture.
(B) Cells derived from TKO spheres after 2 weeks in suspension culture. Similar results were seen with cells derived from RB1/ MEF spheres.
(C) Quantification of side population (SP) (Hoechst, Abcg2+, CD133+) cells.
(D) TKO and RB1/ MEF sphere-derived cells were separated into SP (Hoechst, CD133+, Abcg2+) and MP (Hoechst+, CD133, Abcg2) and placed in
culture (day 0). Then at the indicated times, the cells were again examined to quantify the appearance of MP cells within the SP population, and SP cells within
the MP population.
(E) Hoechst SP cells from RB1/ MEF spheres.
(F) Higher-power view of a cell from (E).
(G) A Hoechst cell in (E) gives rise to a Hoeschst+ cell on day 2 in culture.
(H) Population of cells arising from a single Hoechst from (E) after 5 days in culture.
(I) Hoechst+ MP Cells.
(J) Higher-power view of a single MP cell.
(K) A Hoechst+ cell gives rise to two additional Hoeschst+ cells on day 2 in culture.
(L) Population of cells arising from a single Hoechst+ after 5 days in culture.
(M) Quantification of SP (white bars) and MP (blue bars) cells arising from single SP or MP cells. Results are from five different single SP or MP cells.
Error bars indicate standard deviations.340 Cell Stem Cell 4, 336–347, April 3, 2009 ª2009 Elsevier Inc.RB1/ MEFs in monolayer culture did not display SP properties
(Figure 3C); however, cells derived from RB1/ MEF spheres
showed a similar SP population to TKOs (Figure 3C).
Another property of SP cells is asymmetric division to give rise
to MP cells, while maintaining their own number (Dalerba et al.,
2007; Dick, 2005; Lobo et al., 2007; O’Brien et al., 2007; Trosko,
2006; Zhang and Rosen, 2006; Knoblich, 2008). We sorted
sphere-derived monolayers of TKOs (Figure S4), leading to a
uniform population of small Hoechst, Abcg2+, CD133+ cells,
denoted SP.While no Hoechst+,Abcg2, CD133cells (denoted
MP) were evident in the sorted SP cells initially, MP cells appeared
after 2 days inculture,and by this time they comprised the majorityWe began by examining wild-type MEFs, TKOs maintained as
subconfluent monolayers, and TKOs derived from spheres for
Hoechst dye exclusion and cell surface expression of Abcg2
and CD133. We found that MEFs and TKOs maintained as
subconfluent monolayers did not exclude Hoechst dye or
express Abcg2 or CD133 on their surface (Figures 3A and 3C;
results not shown). However, 10% of sphere-derived TKOs
at P0 were Hoechst, Abcg2+, CD133+ (Figures 3B and 3C).
Notably, these Hoechst, Abcg2+, CD133+ cells were much
smaller (5 mm in diameter) than the MP, which consisted of
Hoechst+, Abcg2, CD133 cells (>10 mm). We then examined
RB1/ cells for SP properties. As with wild-type MEFs, the
Cell Stem Cell
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Figure 4. SP Cells Express ESC Markers, They Overexpress the EMT Transcription Factor Zeb1, and They Have a CD44-High/CD24-Low
mRNA Pattern; Zeb1 Knockdown Leads to Induction of CD24 mRNA
(A) TKO sphere-derived cells were separated into SP (Hoechst, CD133+, Abcg2+) and MP (Hoechst+, CD133, Abcg2) by cell sorting, and real-time PCR was
used to assess the relative level of ESC mRNAs in these populations compared to ESCs maintained in monolayer culture in the presence of Lif. Results shown are
normalized to b-actin (Actb) mRNA, but similar results were seen with normalization to Gapdh mRNA or b2-microglobulin mRNA (results not shown).
(B) Zeb1, but not Zeb2, Snai1, or Snai2 mRNA is induced in SP cells compared to the MP or unsorted sphere-derived cells, and this induction correlates with
a CD44-high/CD24-low pattern, repression of E-cadherin (cdh1), and induction of smooth muscle actin (SMA).
(C) Zeb1 mRNA is induced in a time course during culture of RB1/ MEFs in suspension. Real-time PCR results are shown.
(D) Knockdown of Zeb1 (Zeb1 sh) but not Zeb2 (Zeb2 sh) induces CD24 mRNA. Lentiviral shRNA constructs were used to infect MEFs and efficiently knock down
Zeb1 and Zeb2 (Figure S5), and real-time PCR results are shown.
Error bars indicate standard deviations.re-express ESC genes. Gene expression in sorted SP and MP
populations of cells derived from spheres was compared to
embryonic stem cells using real-time PCR. The SP cells from
spheres expressed mRNAs for stem cell markers in levels similar
to those seen in ESCs (Figure 4A). These markers included
Oct-4, Sox2, c-myc, and Klf-4, whose retroviral re-expression is
sufficient for reprogramming of MEFs to pluripotency (Takahashi
and Yamanaka, 2006; Okita et al., 2007; Wernig et al., 2007;
Jaenisch and Young, 2008). Conversely, there was little expres-
sion of the stem cell mRNAs in the MP cells. These results suggest
that the Oct-4+ and Nanog+ cells we observe in spheres corre-
spond to SP cells, and that as SP cells divide asymmetrically
ESC genes are silenced in the MP daughter cells.
Zeb1 mRNA Is Induced in SP Cells, and This Is
Associated with Downregulation of E-cadherin mRNA,
Induction of Smooth Muscle Actin mRNA, and a CD44-
High/CD24-Low mRNA Expression Pattern
Overexpression of E box binding transcriptional repressors
including Snai, twist, and Zeb family members classically leads
to repression of E-cadherin (Cdh1) and EMT, and Snai1 repres-
sion of E-cadherin and EMT appears to be mediated at least in
part through induction of Zeb1 and Zeb2 (Peinado et al., 2007).of the culture (Figure 3D). The percentage of MP cells increased
further by day 8 in culture (Figure 3D). We then followed SP cells
derived from RB1/ MEFs in culture. As with TKOs, these cells
also gave rise to MP cells while maintaining their original number
(Figure 3D). Next, we analyzed single SP cells from RB1/
MEFs in culture. As with the entire sorted population, during the
course of 5 days, the single SP cells gave rise to MP cells, but their
original number remained constant (Figures 3E–3H and 3M).
Next, we analyzed the sorted MP cells. These cells were prolif-
erative, but they did not appear to divide asymmetrically to give
rise to SP cells (Figure 3D). Indeed, we followed five isolated MP
cells, and we only observed symmetrical division to yield MP
cells (Figures 3I–3M). Taken together, it appears that SP cells
from both TKO and RB1/ spheres give rise to MP cells via
asymmetric division, and that the MP cells in turn divide symmet-
rically to increase their number in the population.
It Is the Hoechst, Abcg2+, CD133+ SP Cells
that Express ESC Markers
The stem cell characteristics attributed to SP populations in
tissues, togetherwith the stemcell property of asymmetricdivision
shown above with the sphere-derived SP cells, led us to ask if the
SP cells correspond to the population of cells in the sphere thatCell Stem Cell 4, 336–347, April 3, 2009 ª2009 Elsevier Inc. 341
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EMT factors can also trigger a CD44-high/CD24-low pattern on
epithelial cells, which is associated with the somatic cells
acquiring stem cell and cancer stem cell properties (Mani et al.,
2008). Therefore, we wondered whether expression of these
EMT transcription factors was induced in the sphere-derived
SP cells. Using real-time PCR, we found that Zeb1 (but not
Zeb2, Snai1, or Snai2) mRNA was induced in SP cells compared
to MP cells (Figure 4B), and that Zeb1 mRNA increased in a time
course of sphere formation in RB1/ MEFs similar to that seen
with Oct-4 and Nanog mRNA (Figures 2B and 4C). Consistent
with upregulation of Zeb1, smooth muscle actin mRNA was
induced in SP cells, whereas E-cadherin mRNA was diminished
(Figure 2B), indicating that SP cells are mesenchymal in gene
expression compared to MP cells.
Next, we asked whether overexpression of Zeb1 mRNA might
coincide with induction of CD44 mRNA and downregulation of
CD24 mRNA in SP cells. Indeed, we found that CD44 mRNA
was induced in SP cells, whereas CD24 mRNA was diminished
(Figure 4B). Flow cytometry demonstrated a similar CD44/
CD24 pattern on the cell surface (results not shown). In addition
to this CD44-high/CD24-low mRNA pattern in the SP cells, it is of
note that CD133 mRNA and protein were also induced in the SP
cells, along with Zeb1 mRNA (Figure 4A).
Both Zeb1 and Zeb2 are expressed in wild-type MEFs (Liu
et al., 2007, 2008), and we were unable to detect CD44 mRNA
in these cells, but CD24 mRNA was expressed (Figure 4D). We
then used lentiviral shRNA constructs to knock down Zeb1 and
Zeb2 in these cells (Figure S5) to determine whether either of
these EMT transcription factors might be important in maintain-
ing repression of CD24. We found that knockdown of Zeb2 had
little effect on the level of CD24 mRNA; however, CD24 mRNA
was significantly induced with Zeb1 knockdown (Figure 4D).
These results provide evidence that Zeb1 is necessary to main-
tain repression of CD24.
Zeb1 Expression Is Required for Viability of SP Cells
and Proliferation of MP Cells Derived
from RB1/ MEF Spheres
Zeb1 was knocked down using lentivirus shRNA in cells prior to
sphere formation and in SP and MP cells derived from spheres
(Figures S5–S8). This knockdown of Zeb1 led to induction of the
cyclin-dependent kinase inhibitors p15INK4b and p21CDKN1a
and growth arrest in monolayer cells prior to sphere formation
(Figure S7). However, these cells were still able to form spheres
in suspension, and these spheres re-expressed ESC genes
such as Oct4 and Nanog, suggesting that Zeb1 is not required
for sphere formation or for re-expression of these ESC genes.
However, the spheres that formed were small, and they did not
increase in size during suspension culture.
Knockdown of Zeb1 in isolated SP cells prevented the cells
from giving rise to MPcells, and it led to roundingof the cells within
18 hr after infection; by day 5 following infection the cells were no
longer viable (Figure S8). By contrast, MP cells did not round up
nor was there a significant loss in viability with Zeb1 knockdown.
However, the cells did not proliferate, and they accumulated
multiple nuclei. These results demonstrate an important role for
Zeb1 in the survival of isolated SP cells and the proliferation of
MP cells.342 Cell Stem Cell 4, 336–347, April 3, 2009 ª2009 Elsevier Inc.RB1/ and TKO MEF Spheres Express Markers
of All Three Embryonic Layers
The appearance of SP cells expressing ESC markers in TKO and
RB1/ MEF spheres, together with the diverse morphology
seen in cells derived from these spheres (Figure 1H), led us to
ask whether there was evidence of differentiation in the spheres
(e.g., analogous to differentiation seen when embryonic stem
cells form embryoid bodies). We used real-time PCR to analyze
mRNA expression in spheres and in cells that had been allowed
to migrate from spheres and reform monolayers on tissue culture
plates. Similar induction of mRNAs for markers of all three
embryonic layers was seen in spheres and sphere-derived
cells (Figures 5A–5C, S1, S3, and S9). These markers included
important developmental transcription factors such as GATA4,
T, Msx1, Foxa2, MyoD, Ascl2, PDX1, PPARg, and islet1, and
components of development signaling pathways including
TGF-b/BMP, notch, wnt, and FGF. However, they also included
markers of terminal differentiation such as cardiac actin, myosin
heavy chain, osteocalcin, aggrecan, E-cadherin, transferin, a-fe-
toprotein (AFP), myelin basic protein, GFAP, tyrosine hydroxy-
lase, b-III tubulin, NCAM, Neurog2, Col9a1, CD19, CD3, CD4,
and CD8.
Next, spheres were fixed and sectioned for immunostaining.
The perimeter of embryoid bodies formed from ESCs contain
early endodermal cells characterized by expression of AFP and
GATA-4, and this region is a site of hematopoietic and endothe-
lial differentiation resembling embryonic yolk sac blood islands
(Burkert et al., 1991). We noted a band of cells around the perim-
eter of RB1/ MEF spheres that resembled endodermal cells
(Figure 6A), and these cells immunostained for AFP (Figures 6D
and 6E). This region also immunostained for GATA-4 and mRNAs
for GATA-4, and the early endodermal transcription factors
Foxa2, PDX1, and Isl1 were also induced in spheres and
sphere-derived cells (Figures 5, S1, and S9). The region also con-
tained a number of cells with eosinophilic cytoplasm (Figure 6B),
and these cells immunostained for a-globin, indicating that they
are erythroid (Figures 6F–6H and S10). These cells also were
brightly stained with benzidine/peroxide, which is specific for
hemoglobin (Figure 6C). While most of these globin+ cells were
nucleated, some of the cells lacked nuclei (Figures 6H and
S10), implying that they may be progressing from erythroblast-
like progenitors toward erythrocytes in the spheres. This perim-
eter region of the spheres also contained cells with elongated
morphology resembling endothelial cells (Figures 6A and 6B),
and indeed these cells immunostained for the endothelial marker
CD31 (Figures 6I and 6J). Although less abundant than the
globin+ cells, cells with morphology of other hematopoietic line-
ages were also evident (Figure S10). Flow cytometry of total
sphere-derived cells revealed that approximately 2% of the pop-
ulation expressed the hematopoietic stem cell marker CD34 and
approximately 1% expressed the B cell marker CD19 (results not
shown). CD34 and CD19 mRNAs were also induced in the
spheres (Figures 5C, S1, and S9). Taken together, our results
provide evidence that, as in embryoid bodies, the perimeter of
the spheres is a site of hematopoietic/endothelial differentiation.
Cells interior to the globin+ cells in spheres displayed epithe-
lial-like morphology (Figure 6C), and these cells expressed the
early epithelial marker E-cadherin (Cdh1) (Figure 6K). Cdh1
mRNA was also induced in the spheres and sphere-derived
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RB1 Pathway and Cancer Stem Cell FormationFigure 5. Sphere Formation Triggers Induction of mRNAs Representative of the Three Embryonic Layers as Well as mRNAs in Important
Developmental Signaling Pathways
(A–F) Real-time PCR was used to analyze the effect of sphere formation on expression of mRNAs representative of different embryonic layers and developmental
signaling pathways. Relative mRNA expression in TKO subconfluent monolayers is compared to TKO spheres that had been in suspension culture for 3 weeks.
See Figures S1 and S9 for similar analysis in RB1/ MEF spheres and cells derived from these spheres. Error bars indicate standard deviations.ESCs. However, isolated SP cells could be used to reform
spheres, which again re-expressed ESC genes along with the
series of genes and transcription factors indicative of formation
of cells representative of all three embryonic layers (Figure S12).
These results provide evidence that SP cells can give rise to
differentiated cells in the spheres, and they suggest that the
niche within the sphere (which may be lost in monolayer culture)
may be important for SP maintenance/differentiation.
SP Cells Form Tumors in Nude Mice
BecausemutationofRB1or inhibitionof theRB1pathway isa hall-
mark of cancer and the SP cells show a pattern of cell surface
expression seen on some cancer stem cells (e.g., CD44-high,
CD24-low, CD133-high, Abcg2+) we wondered whether the SP
cells formed during sphere formation mayhave the tumor-forming
capability of cancer stem cells. To determine whether tumorigenic
cells were being generated by sphere formation, small spheres of
TKO or RB1/ MEFs after 2 weeks in suspension culture were
injected subcutaneously into the hind limb of nude mice. Tumors
arose from these spheres. The tumors were all spindle cell
sarcomas, but they also contained scattered spherical whorls
with eosinophilic centers (Figure 7C). As a negative control,
tumors did not arise following injection of 100,000 TKO MEFs
that were trypsinized from subconfluent monolayers and injected
into the nude mice (results not shown). To determine if this tumor-
forming activity was maintained in sphere-derived cells that had
migrated from spheres to reform a monolayer, we trypsinized
such monolayers of sphere-derived TKOs or RB1/ MEFs and
injected 50,000 cells into the nude mice. Tumors formed with
both cell types, and they were histologically indistinguishable
from those formed with the spheres (Figures 7C, S13, and S14).
In each case, the tumors again were spindle cell sarcomas, andcells, as was mRNA for the epithelial progenitor marker Ker15
(Figures S1 and S9). We also noted immunostaining for the
neuronal marker b-III tubulin (Figure 6L). These b-III tubulin+ cells
were generally in clusters or spherical structures. Immunostain-
ing for all of the markers of differentiation increased in a time-
dependent fashion from 4 days in suspension culture out to at
least 24 days. And by 24 days, a higher percentage of the b-III
tubulin+ cells exhibited elongated morphology characteristic of
neurons.
Similar staining for globin, AFP, and CD31 was also seen in the
periphery of spheres derived from TKO cells (results not shown).
Again, b-III tubulin+ cells were found primarily in clusters con-
taining cells with neuronal morphology, and cells in these clus-
ters also expressed a-tyrosine hydroxlyase (a marker of dopami-
nergic neurons) (Figure S11). Cells surrounding some of these
neuronal clusters showed elongated projections and the immu-
nostained for both tyrosine hydroxylase and the motor neuron
marker Isl1 (Figure S11). In addition to these neuronal markers,
immunostaining for markers of oligodendrocytes (myelin basic
protein) and glia/astrocytes (GFAP) was also evident in distinct
regions of the spheres (Figure S11). Expression of these neural
markers is consistent with the induction of mRNA for various
neural markers in the spheres and sphere-derived cells (Figures
5B, S1, and S9). Based on these real-time PCR and immunos-
taining results, we conclude that in addition to generation of cells
with SP properties, sphere formation with RB1/ and TKO
MEFs is triggering generation of cells expressing markers of all
three embryonic layers. Attempts to differentiate SP cells in
monolayer culture led only to production of MP cells lacking
expression of ESC genes or differentiation markers. In these
experiments cells were cultured on laminin, fibronectin, gelatin,
or plastic and exposed to various differentiation protocols forCell Stem Cell 4, 336–347, April 3, 2009 ª2009 Elsevier Inc. 343
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centers (Figures 7C and S13). Thesewhorls were devoid of cancer
cells, and they appeared histologically similar to regions evident in
spheres in culture, which expressed markers of neuronal differen-
tiation (Figure S11). Indeed, immunostaining of tumor sections
A B C
D1 D2 D3 D4
E1 E2 E3 E4
F1 F2 F3 F4
G1 G2 G3 G4
H1 H2 H3 H4
I1 I2 I3 I4
J1 J2 J3 J4
K1 K2 K3 K4
L1 L2 L3 L4
Figure 6. Immunostaining of RB1/ Spheres Shows Expression of
Markers Representative of the Three Embryonic Layers
(A) H&E-stained section showing the perimeter of an RB1/ MEF sphere after
2 weeks in suspension culture. Note the band of cells with endodermal
morphology. An arrow denotes the edge of the sphere.
(B) H&E staining showing a lower-power view of the perimeter of the sphere in
(A). Note cells with epithelial-like morphology in the interior region of the
sphere.
(C) A section of the sphere in (A) and (B) was stained with benzidine/peroxide,
which produces a dark blue reaction in the presence of hemoglobin.
(D–L) Immunostaining of sections of RB1/ MEF spheres. A Nomarski image
is shown on the left in each panel, followed by immunostaining, DAPI staining,
and a merged image on the right. Arrows denote the same position in each
panel. AFP, a fetoprotein; HB, globin; Tubb3, b III tubulin; Cdh1, E-cadherin.344 Cell Stem Cell 4, 336–347, April 3, 2009 ª2009 Elsevier Inc.revealed that these whorls expressed b-III tubulin, and as with
spheres in culture, no other regions of the tumor expressed b-III
tubulin (Figure S13).
Next, we injected different numbers of sorted SP and MP cells
into nude mice to assess which population was tumorigenic. Two
independent experiments were performed with two injections of
each cell number in the following experiments. Initially, 50,000,
20,000, 5,000, and 1,000 MP cells were injected. While tumors
formed with each injection of 50,000 MP cells (523 ± 93 mg after
31 days), no tumors were observed in any injection with 20,000 or
fewer MP cells, even after 2 months (Figure 7B). Next, we injected
5,000, 2,000, 500, and 100 SP cells. Tumors formed with every
injection of the SP cells, and these tumors grew rapidly (813 ±
279 mg at 3 weeks with 100 SP cells injected; Figure 7A). Based
on these results, we concluded that SP cells are the primary initi-
ators of tumor formation among the sphere-derived cells.
However, it is of note that the tumors formed from SP and MP
cells were histologically distinct (Figures 7D–7H). Although the
MP tumors were spindle cell sarcomas, they lacked the b-III
tubulin+ spherical whorls seen with injection of unsorted
sphere-derived cells. Additionally, the number of whorls seen in
the SP cell tumors was greater than that seen with the mixed pop-
ulation of sphere-derived cells (Figures 7E–7H). The SP tumors
also contained clusters of cells expressing nuclear Oct-4 and
Nanog scattered throughout the tumor (Figures 7I–7L), suggest-
ing that SP cells are maintained in the forming tumor. These
results provide evidence that the SP cells not only can give rise
to cells expressing markers of differentiation in the spheres and
in the nude mice but also are tumorigenic and thus appear to
be functioning as cancer stem cells. MP cells in high numbers
were able to give rise to cancer cells in the mice, but not the differ-
entiated cells, implying that the MP cells represent cancer cells
generated by the SP cells.
DISCUSSION
Beyond retinoblastoma, RB1 is also frequently mutated in oste-
osarcoma and small-cell lung cancer, and patients heterozygous
for RB1 have significantly increased risk for developing these
cancers (Sa´bado Alvarez, 2008; Kansara and Thomas, 2007).
Indeed, tumors derived from TKO and RB1/ MEFs contained
cells resembling spindle cell sarcomas. Moreover, the RB1
family is regulated by phosphorylation mediated by cdks, and
in tumors where RB1 is not mutated the pathway is inactivated
by hyperphosphorylation of family members (Kaye, 2002; Du
and Pogoriler, 2006; Frolov and Dyson, 2004; Lowe and Sherr,
2003). Thus, loss of the RB1 pathway appears to be a hallmark
of most if not all cancers. The loss of cell-cycle control when
the RB1 pathway is disrupted is thought to play an important
role in the initiation of tumor cell proliferation. However, beyond
tumor expansion, we propose that the loss of cell contact inhibi-
tion when the RB1 pathway is inhibited leads to outgrowth into
sphere-like structures where cell-cell contacts predominate,
and these conditions in the advancing cancer trigger reprogram-
ming of somatic cells to cells with properties of cancer stem cells
(Figure 7M). Even though RB1/ MEFs were contact inhibited
in monolayer culture, they could still form spheres when placed
in suspension culture and generate SP cells with properties of
cancer stem cells. While similar spheres formed with wild-type
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Figure 7. SP Cells Are the Primary Tumori-
genic Population in the Spheres, and
Tumors Derived from These Cells Consist
of Cancer Cells and Neuronal Whorls
(A) Tumors formed in nude mice 3 weeks after
injection of 100 SP cells subcutaneously into the
hind leg.
(B) Tumors failed to form when 20,000 MP cells
were injected.
(C) H&E section of a tumor formed following injec-
tion of 50,000 sphere-derived cells. Arrows indi-
cate whorls.
(D) H&E section of a tumor formed following injec-
tion of 50,000 MP cells. Note the absence of whorls.
(E) H&E section of a tumor formed 3 weeks after
injection of 100 SP cells. Note the presence of
numerous closely packed whorls with eosinophilic
centers (arrows).
(F)Higher-powerviewofa whorl in the tumor from(E).
(G) Nomarksi image of a section of the tumor in (E).
(H) Immunostaining of the section in (G) for b III
tubulin. Arrows indicate the same position in (G)
and (H). Only the whorls immunostained, and
tumors derived from MP cells lacked these whorls
and did not immunostain.
(I and J) Nuclear immunostaining for Oct-4 in
a section of an SP cell tumor. The boxed region
in (I) is shown at higher power in (J).
(K and L) Nuclear immunostaining for Nanog in
a section of the SP tumor. (L) is a higher-power
view of the section.
(M) Model proposing a pathway for generation of
cells with properties of cancer stem cells from dif-
ferentiated somatic cells. See text for discussion.itor cells correspond to the SP. In support of this notion, isolated
SP cells could reform spheres and again induce ESC genes and
a series of differentiation markers. Furthermore, injection of SP
cells into nude mice led not only to production of what appeared
to be a homologous population of cancer cells (spindle cell
sarcoma), but also to neuronal cells segregated in whorls in
a niche distinct from the cancer cells. While wild-type ESCs
form teratomas when injected into nude mice, it is of note that
TKO ESCs formed spherical structures expressing early neuronal
markers in nude mice (Dannenberg et al., 2000). In this way, the
SP cells derived from TKO and RB1/ MEF spheres appear to
resemble TKO ESCs.
Recent studies have demonstrated that overexpression of
EMT transcription factors in epithelial cells can trigger the
CD44-high/CD24-low expression pattern that is thought to be
important for generation of breast cancer stem cells (Mani
et al., 2008). We also observed induction of CD44 and diminished
expression of CD24 mRNAs in SP cells. While we did not see
a change in expression of the EMT factors Snai1, Snai2, or
Zeb2, Zeb1 mRNA expression was induced in SP versus MP
cells. Additionally, this elevated expression of Zeb1 was accom-
panied by repression of E-cadherin and induction of smooth
muscle actin in the SP cells, suggesting a relatively mesenchymal
expression pattern compared to MP cells. Zeb1 is directly
repressed by E2F-RB1 family complexes, which appears to limit
its expression to proliferating cells in vivo (Liu et al., 2007, 2008),
and the downregulation of RBL1 and RBL2 initially during sphere
formation may facilitate this induction during sphere formation.MEFs and differentiated cells were generated in these spheres
(results not shown), neither these wild-type spheres nor cells
derived from the spheres were able to form tumors in nude
mice, emphasizing the importance of RB1/ mutation in gener-
ation of tumor cells in the spheres. Our studies are consistent
with previously published results implying that cells with proper-
ties of cancer stem cells can be generated from somatic cells,
and they suggest a pathway linked to tumor outgrowth for gener-
ation of such cells in more advanced tumors.
Interestingly, the SP cells with properties of cancer stem cells
isolated from spheres of MEFs mutant in the RB1 pathway
expressed ESC genes including Oct-4, Sox-2, Nanog, Klf4, and
c-myc, and this was accompanied by induction of genes in path-
ways known to be important for ESCs maintenance such as
TFG-b/BMP, Wnt, Notch, hedgehog, and FGF. To our knowl-
edge, this is the first example that silenced endogenous ESC
genes such as Oct-4 and Nanog can be reactivated in differenti-
ated somatic cells. Beyond production of cancer cells, a number
of cells in TKO andRB1/ MEF spheres express markers repre-
sentative of all three embryonic layers, reminiscent of what
occurs in embryoid bodies derived from ESCs. It has been
demonstrated previously that cancer stem cells can also give
rise to differentiated cells along with cancer cells (Dirks, 2008).
While we are unsure of the steps involved in the differentiation
process in the spheres, it is interesting to speculate that sphere
formation is reprogramming differentiated somatic cells with
a mutant RB1 pathway back to a multipotential phenotype
capable of generating differentiated cells, and that these progen-Cell Stem Cell 4, 336–347, April 3, 2009 ª2009 Elsevier Inc. 345
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consensus Zeb1 binding sites, suggesting that CD24 may be
a direct target of Zeb1 repression in SP cells. Indeed, knockdown
of Zeb1 but not Zeb2 led to induction of CD24 mRNA, suggesting
that Zeb1 is important in repressing CD24 expression. Zeb1
expression is tightly linked to cell proliferation in vivo, and it
directly represses the cdk inhibitors p15INK4b and p21CDKN1a,
which inhibit the cell cycle (Liu et al., 2008 and references therein).
Heterozygous mutation of Zeb1 is sufficient for induction of both
of these genes, and it leads to premature senescence of MEFs in
culture, and induction of p15INK4b in Zeb1/ cells in vivo is
linked to diminished mesenchymal and CNS progenitor cell
proliferation during development with accompanying develop-
mental defects (Liu et al., 2008). Knockdown of Zeb1 inhibited
growth of spheres in suspension, it prevented generation of MP
cells from isolated SP cells, and it led to the eventual loss of SP
cell viability in culture. In this regard, it is of note that the
Drosophila homolog of Zeb1, Zfh1, was recently shown to be
necessary for viability of stem cells in the testis (Leatherman
and Dinardo, 2008), implying an important role in normal stem
cell viability.
EXPERIMENTAL PROCEDURES
Cells and Cell Culture
RB1 family mutant mouse embryo fibroblasts and control wild-type MEFs were
kind gifts from T. Jacks, J. Sage, and G. Leone. TKOs derived from four sepa-
rate embryos were used in the experiments described here with similar results.
Cells were analyzed beginning at passage 4, but similar results were also seen
at passage 11. The cells were cultured in DMEM with 10% heat-inactivated fetal
bovine serum. Mouse embryonic stem cells were obtained from M. Ratajczak.
One unit/ml of LIF (Chemicon) was added to embryonic stem cell cultures.
Immunohistochemistry
Slides were immunostained as described previously (Liu et al., 2008). All
primary and secondary antibodies are described in Tables S1–S3. Primary anti-
bodies were incubated at 4C overnight, and after three washes with PBS,
slides were incubated at 1:200–500 dilution with secondary antibodies conju-
gated with either Cy3 or Alexa Fluor 488 at room temperature for 60 min. After
three washes with PBS, slides were mounted with coverslips using either
anti-fade medium Permount (Fisher) or Vectashield DAPI medium (Vector
Laboratories, Inc.), and images were captured either with an Olympus confocal
microscope or with a Zeiss fluorescent microscope.
Tumor Formation in Nude Mice
Either small spheres1 mm in diameter, after 2 weeks in suspension culture, or
trypsinized monolayers of cells derived from spheres were injected subcutane-
ously into the hind limb of Balb/c nude mice as described (Telang et al., 2006).
Tumors were fixed in 10% buffered formalin, embedded in paraffin, sectioned
at 5 mm, and stained with H&E or used for immunostaining (Liu et al., 2008).
Identification and Isolation of SP and MP Cells
Cells were trypsinized from tissue culture plates, suspended in prewarmed
DMEM containing 2% FBS and 10 mM HEPES, and stained with 5 mg/ml of
Hoechst 33342 dye (Molecular Probes) for 90 min at 37C. Cells were then
washed and resuspended in HBSS containing 2% FBS and 10 mM HEPES.
Before cell sorting, 2 mg/ml propidium iodide (Sigma) was added to exclude
nonviable cells. SP cells were identified and isolated by MoFlo cell sorter
(Dako; Carpinteria, CA) after excitation of the Hoechst dye with a 350 nm UV
laser (100 mW power was used). Fluorescence light emitted by cells was
directed toward a 510 nm DCLP dichroic mirror and collected simultaneously
by two independent detectors following a 450/65 nm and a 670/30 nm band
pass filters, respectively. Cells were analyzed on a linearly amplified fluores-
cence scale.346 Cell Stem Cell 4, 336–347, April 3, 2009 ª2009 Elsevier Inc.For immunostaining, Hoechst 33342-treated cells were spun down, washed
twice with PBS, and incubated either with rat anti-Abcg2 (1:20) or mouse anti-
CD133 (1:50) for 1 hr at room temperature. No blocking serum was used. Cy3-
conjugated anti-rat IgG (1:200) (Chemicon) and Alexa Fluor 488-conjugated
anti-mouse IgG (1:200) (Molecular Probes) were the secondary antibodies
for anti-Abcg2 and anti-CD133, respectively. Images were captured with an
Olympus confocal microscope.
RNA Extraction and Real-Time PCR
RNA was extracted using TRIzol, and cDNA was synthesized using the Invitro-
gen RT kit (Invitrogen), and SYBR Green real-time PCR was performed using
a Stratagene Mx3000P Real-Time PCR system (Liu et al., 2008). PCR primers
are described in Table S1. A mouse stem cell real-time PCR Array was also
analyzed (SuperArray, APMM-405). Three independent samples, each in trip-
licate, were analyzed for each real-time PCR condition.
SUPPLEMENTAL DATA
The Supplemental Data include supplemental text, 14 figures, and three tables
and can be found with this article online at http://www.cell.com/cell-stem-cell/
supplemental/S1934-5909(09)00101-5.
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